1-4 of 4
Emanual Maverakis
Close
Sort by
Journal Articles

A Phase I California Cancer Consortium Study of Blinatumomab/Lenalidomide in Relapsed/Refractory Non-Hodgkin Lymphoma: Updated Results and Immune Correlative Analyses

Tamer Othman, Christopher Ruel, Paul Frankel, Alexander A. Merleev, Guillaume Luxardi, Emanual Maverakis, Mehrdad Abedi, Raghuveer Ranganathan, Jasmine Zain, Lihua E Budde, Matthew Mei, Aaron S Rosenberg, Rasmus T Hoeg, Caitlin Costello, Francine M. Foss, Basem M. William, H. Kent Holland, Miguel Villalona-Calero, Elad Sharon, Joseph M Tuscano
Journal: Blood
Blood (2022) 140 (Supplement 1): 9446–9447.
https://doi.org/10.1182/blood-2022-167173
Published: 2022
Journal Articles

Increased efficacy of dual proinflammatory cytokine blockade on acute GVHD while maintaining GVT effects

Brief Report
Lam T. Khuat, Logan V. Vick, Cordelia Dunai, Craig P. Collins, Shyam K. More, Catherine T. Le, Chien-Chun Steven Pai, Kevin M. Stoffel, Emanual Maverakis, Robert J. Canter, Arta M. Monjazeb, Dan L. Longo, Mehrdad Abedi, Eunju Choi, Bruce R. Blazar, Maneesh Dave, William J. Murphy
Journal: Blood
Blood (2021) 138 (24): 2583–2588.
https://doi.org/10.1182/blood.2021011216
Published: 2021
Includes: Supplemental data
Journal Articles

Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Lam T. Khuat, PhD, Catherine T. Le, BS, Chien-Chun Pai, DVM, PhD, Robin Shields-Cutler, PhD, Shernan Holtan, MD, Armin Rashidi, MD PhD, Sarah Parker, MD, Dan Knights, PhD, Jesus I. Luna, PhD, Cordelia Dunai, MS, Ziming Wang, PhD, Ian R. Sturgill, MS, Kevin Stoffel, MS, Alexander A. Merleev, PhD, Emanual Maverakis, MD, Helen Raybould, PhD, Mingyi Chen, MD PhD, Robert J. Canter, MD, Arta M. Monjazeb, MD PhD, James L. M. Ferrara, MDDSc, John E. Levine, MDMS, Dan L. Longo, MD, Mehrdad Abedi, MD, Bruce R. Blazar, MD, William J. Murphy, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1922.
https://doi.org/10.1182/blood-2019-127743
Published: 2019
Journal Articles

a Phase I California Cancer Consortium Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory CD20+ B-Cell Lymphoma; Efficacy, Safety and Immune Correlative Analysis

Joseph Tuscano, MD, Susan Groshen, PhD, Denice Tsao-Wei, Emanual Maverakis, MD, Paul R. Kaesberg, MD, Tanya Siddiqi, MD, Leslie Popplewell**, MD, Sikander Ailawadhi, Myo Htut, Robert W. Chen, MD, Mark Kirschbaum, MD, Mark T. Schroeder, MD, Brian A Jonas, MD PhD, Ted Wun, MD FACP, FRCPA, Neil Palmisiano, MD, David F. Claxton, Edward Newman, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4086.
https://doi.org/10.1182/blood.V130.Suppl_1.4086.4086
Published: 2017